Merck Misled USPTO In Singulair Patent Case: Teva
Generic-drug maker Teva Pharmaceuticals USA Inc. on Monday sought to compel Merck & Co. Inc. to divulge what Teva alleges is prior art information that could undermine a patent for the...To view the full article, register now.
Already a subscriber? Click here to view full article